Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Short Communication
Newer human inosine 5′-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents
Chetan P. ShahDepartment of Pharmaceutical Chemistry, SPP School of Pharmacy and Technology Management, SVKM’s NMIMS, Mumbai, India
http://orcid.org/0000-0001-8074-7697View further author information
http://orcid.org/0000-0001-8074-7697View further author information & Prashant S. KharkarDepartment of Pharmaceutical Chemistry, SPP School of Pharmacy and Technology Management, SVKM’s NMIMS, Mumbai, IndiaCorrespondence[email protected]
http://orcid.org/0000-0003-1955-7223View further author information
http://orcid.org/0000-0003-1955-7223View further author informationRelated Research Data
Modulation of cancer pathways by inhibitors of guanylate metabolism.
Source:
Elsevier BV
Mycophenolic Acid-Induced Apoptosis in Neuroblastoma
Source:
Wiley
Mycophenolic acid analogs with a modified metabolic profile.
Source:
Elsevier BV
Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Source:
Informa UK Limited
Inosine 5´-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives
Source:
Future Science Ltd
Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target.
Source:
American Chemical Society (ACS)
Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Source:
SAGE Publications
Drugs acting on central nervous system (CNS) targets as leads for non-CNS targets
Source:
F1000 Research Ltd
Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade.
Source:
Bentham Science Publishers Ltd.
Development of a Method for Converting a TAK1 Type I Inhibitor into a Type II or c-Helix-Out Inhibitor by Structure-Based Drug Design (SBDD)
Source:
Pharmaceutical Society of Japan
Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review.
Source:
Ovid Technologies (Wolters Kluwer Health)
Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid
Source:
American Association for Cancer Research (AACR)
IMP dehydrogenase: structure, mechanism, and inhibition.
Source:
American Chemical Society (ACS)
Synthesis and antitumor activity of conjugates of muramyldipeptide or normuramyldipeptide with hydroxyacridine/acridone derivatives.
Source:
American Chemical Society (ACS)
Linking provided by
